This study uncovered a competing endogenous RNA (ceRNA) network associated with CCND1 in HNSCC, identifying the TPRG1-AS1-hsa-miR-363-3P-MYO1B pathway as a potential diagnostic marker and therapeutic target, and shed light on the molecular mechanisms underlying HNSCC progression and prognosis (Li et al., 2023). Here, MYO1B is linked to head and neck squamous cell carcinoma.